dystrophin

green light go go ahead advance yes streetlight

Biotech

FDA advisers narrowly support Sarepta's DMD gene therapy

FDA advisers have narrowly voted in favor of Sarepta’s gene therapy for patients with Duchenne muscular dystrophy.

Max Bayer May 12, 2023 7:09pm

DNA genomics precision medicine

Sarepta sees muscle gains with DMD gene therapy

Oct 4, 2018 11:00am